GEN
NASDAQ · Technology
Gen Digital Inc
$22.68
+2.49 (+12.33%)
GEN News30 articles
KC-135 Tanker Emergency Over Qatar Renews Scrutiny of Aging Fleet
A US KC-135 Stratotanker declared an emergency over Qatar, highlighting the strain on the aging tanker fleet amid heightened tensions with Iran.
Genmab Shares Slide on Profit Dip Despite Strong Revenue Growth
Genmab shares tumbled nearly 10% in Copenhagen after Q1 net profit plunged to $53M, weighed down by Merus deal costs and elevated R&D, despite a 25% revenue surge to $896M.
Nebius Eyes Record Highs After $643M Eigen AI Deal, Q1 Earnings in Focus
Nebius shares hover near record highs after a $643M deal for Eigen AI, with Q1 earnings due May 13 set to test the stock's momentum.
Anthropic Unveils AI Agent Templates for Financial Sector Automation
Anthropic released 10 prebuilt AI agent templates for banks and insurers, automating pitchbooks, KYC, and accounting. FIS partners on AML agents; BMO and Amalgamated Bank pilot.
GeneDx Shares Halved After Revenue Forecast Cut, Reimbursement Woes
GeneDx stock crashed 51% after slashing its 2026 revenue outlook, as reimbursement rates and product mix weighed on first-quarter results.
Tech Rally Resurgent: Intel, Micron, SanDisk Lead Nasdaq Higher
The Nasdaq rose 0.83% Tuesday, driven by Intel, Micron, and SanDisk as AI optimism returned. Oil's pullback eased rate worries, extending April's record rally.
Netflix, Microsoft, and Others Chart Divergent Cash Strategies
Netflix adds $25B to buybacks after deal breakup; Microsoft plans $190B AI spend. PulteGroup and Mobileye also expand repurchases as stocks dip.
Nebius Shares Surge on $643 Million Eigen AI Acquisition
Nebius Group acquires Eigen AI for $643M in cash and stock, sending NBIS shares up nearly 12% as the company strengthens its AI inference capabilities.
Nebius Acquires Eigen AI for $643M to Tackle Inference Cost Challenge
Nebius Group NV acquires Eigen AI for $643M to expand AI inference software, addressing rising costs in AI cloud computing. Shares rose 11.8%.
Nebius Acquires Eigen AI for $643M to Boost Inference Capabilities
Nebius Group N.V. acquires Eigen AI for $643M to advance AI inference, with shares jumping 11.3%.
Canada Targets Crypto ATMs and Establishes Federal Financial Crimes Agency
Canada plans to ban cryptocurrency ATMs and establish a new Financial Crimes Agency with police powers, citing over C$704 million in fraud losses in 2025.
General Dynamics Soars on Strong Submarine, Jet Orders; 2026 Outlook Raised
General Dynamics shares surged 10.9% after Q1 earnings and revenue topped estimates, driven by submarine and Gulfstream jet orders, lifting its 2026 outlook.
Generac Surges on Raised 2026 Outlook as Data Center Demand Drives Growth
Generac raised its 2026 outlook after Q1 net sales rose 12%, driven by data center demand. Shares jumped 11% as adjusted EPS of $1.80 topped estimates.
Biogen Lowers 2026 Profit View Despite Q1 Beat; Leqembi Sales Soar 74%
Biogen lowered its 2026 adjusted earnings outlook to $14.25-$15.25 per share after Q1 results topped estimates. Leqembi sales jumped 74% to $168M globally.
Regeneron Q1 Results Top Estimates, Eylea Challenges Loom
Regeneron reported strong Q1 results with revenue up 19% and earnings above estimates, but Eylea sales declined and an FDA delay on a new syringe manufacturer weighs on shares.
Analysts See Divergent Paths for Microsoft, Alphabet, and Oracle in AI Cloud Race
Analysts forecast Oracle with the most upside, Microsoft facing a tough earnings bar, and Alphabet with less room to run as AI cloud spending takes center stage this earnings week.
Guggenheim Initiates Buy on Shake Shack Ahead of Q1 Earnings
Guggenheim initiated Shake Shack at Buy with a $120 target, boosting shares 5.6%. The call comes before May 7 earnings, with Q1 visits up nearly 20%.
Regeneron Stock Rises on Drug Pricing Deal, Free Gene Therapy Offer
Regeneron shares gained 2.6% Thursday following a drug-pricing pact with the U.S. and a plan to offer its new gene therapy Otarmeni at no cost. Analysts remain optimistic ahead of Q1 results.
Alphabet Unveils New AI Agents and Chips Ahead of Earnings Report
Alphabet shares traded near $340 after Google unveiled new enterprise AI software and custom chips at Cloud Next, ahead of Q1 earnings on April 29.
Analysts Boost Apple Outlook Ahead of Earnings, Highlight Memory Cost Divergence
Apple shares gained as Morgan Stanley reiterated a bullish $315 price target ahead of earnings, while BNP Paribas upgraded the stock and cut Qualcomm, citing diverging abilities to handle higher memory costs.
Middle East Turmoil Hits Luxury Watch Sales at Geneva Fair
The Watches and Wonders Geneva fair concluded amid a luxury sector shock, as major brands reported steep sales declines in the Middle East due to regional conflict, impacting Swiss watch exports for a second consecutive year.
Hang Seng Rallies on Strong China GDP, Sigenergy Soars in Debut
Hong Kong stocks advanced sharply as China's first-quarter economic growth exceeded expectations, lifting the Hang Seng Index by 1.7%. Technology and electric vehicle battery shares were standout performers.
Plug Power Surges on Major Quebec Hydrogen Deal Ahead of Investor Tour
Plug Power shares rallied sharply following a significant electrolyzer contract award in Quebec. Company leadership is commencing a Canadian investor roadshow to discuss financial progress and growth strategy.
CenterPoint Energy Sees Divergent Institutional Moves Ahead of Q1 Report
Institutional investors showed mixed sentiment toward CenterPoint Energy in Q4, with Aberdeen and Stratos cutting positions while Allspring added shares. The utility reports first-quarter results on April 23.
Plug Power Secures Major Electrolyzer Contract for Quebec Green Hydrogen Project
Plug Power has been selected to provide a 275-megawatt electrolyzer system for Hy2gen Canada's Courant green hydrogen project in Quebec, sending its shares up 7%.
Biogen Acquires Apellis in $5.6B Deal, Adding Eye and Kidney Drugs
Biogen has entered a definitive agreement to acquire Apellis Pharmaceuticals for approximately $5.6 billion. The deal includes a $41 per share cash offer plus contingent value rights.
European Gas Prices Retreat Amid Profit-Taking, EU Considers Emergency Steps
European natural gas prices declined Tuesday as traders locked in gains, with the Dutch TTF benchmark dropping 2.5%. The European Commission is preparing emergency measures as storage levels remain critically low.
Pfizer Shares Reach New Peak Amid Divergent Views on Future Growth
Pfizer shares surged to a 52-week high of $28.30, driven by robust quarterly results and promising oncology data. Analysts remain divided on whether the stock's rally is sustainable given looming growth challenges.
Biogen to Acquire Apellis in $5.6B Deal, Adding Rare Disease Portfolio
Biogen has entered an agreement to acquire Apellis Pharmaceuticals for approximately $5.6 billion in cash. The deal provides Apellis shareholders $41 per share upfront, with potential additional payments based on sales performance of the eye drug Syfovre.
Uber's Blacklane Acquisition Fuels $100 Share Price Debate Amid Analyst Divergence
Uber Technologies advanced 1.4% to $70.15 after announcing its acquisition of chauffeur service Blacklane, while Wells Fargo trimmed its price target to $95. The company reported $52 billion in 2025 revenue and 202 million monthly active users.